3ème conférence investisseurs annuelle H.C. Wainwright BioConnect au NASDAQ Date : mardi 20 mai 2025 Horaire : 23 h 00 CEST / 17 h 00 EDT Lieu : New York, NY (États-Unis) Participant : Bart van Rhijn, ...

Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced ...

Saint Herblain (France), le 12 mai 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’agence de santé américaine Food and Drug ...

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms outlook for full ...

Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025 ...

H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ Date: Tuesday, May 20, 2025 Time: 5:00 pm EDT / 11:00 pm CEST Location: New York, NY Presenters: Bart van Rhijn, Chief Financial & ...

Valneva is committed to upholding the highest safety standards and has engaged proactively with health authorities in all territories where IXCHIQ ® is licensed to provide timely information about all ...

Apple cider vinegar is a go-to remedy. Soak a cotton ball in vinegar, apply it to the skin tag, and secure it with a bandage ...

Discover the 6 best fat burners for women in 2025. Top OTC & online weight loss pills from Wolfson Brands (UK) Limited to ...

Les résultats confirment le bénéfice potentiel de l’éfruxifermine (EFX) pour déclencher une amélioration de la fibrose chez les patients atteints de cirrhose compensée (fibrose F4) due à une MASH ; le ...

All of the shares in the public offering, including the full exercise of the underwriter’s option, were sold by Exagen, with gross proceeds to Exagen of approximately $20.2 million, before deducting ...

ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on ...